U.S. Physical Therapy, Inc.
NYSE:USPHMedical - Care Facilities
+$0.12 today
- Market cap
- $1.42B
- Beta
- 1.16
- P/E (TTM)
- 810.7
- EPS (TTM)
- $0.08
- Dividend yield
- 2.89%
Volume 0.33M
Average 0.20M
USPH Deferred Income Tax
The difference between tax expense recognized and tax actually paid in cash during the period.
U.S. Physical Therapy, Inc.NYSE: USPH
Deferred Income Tax · Q1 FY2026 · quarter ended Mar 2026
Deferred income tax dips below year-ago levels
Q1 FY2026 deferred income tax of $3.29M fell 37.3% year over year, behind the +9.1% change in trailing-twelve-month deferred income tax. Sequentially, it rose 1253.1% from the prior quarter. Over 3 fiscal years it compounded at +38.3% a year.
Context
- Deferred income tax amounted to 1.5% of revenue in FY2025, up 0.7 pp from a year earlier.
- Deferred income tax increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -37.3% toward the trailing-twelve-month pace of +9.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Deferred Income Tax history
USD · from the cash flow
- Latest · FY2025
- 11.41M USD
- Year-over-year change
- +112.6%
- 4-year CAGR
- +19.0%
| Period | Period end | Deferred Income Tax | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.41M | +112.6% |
| FY2024 | 2024-12-31 | 5.37M | +19.5% |
| FY2023 | 2023-12-31 | 4.49M | +4.2% |
| FY2022 | 2022-12-31 | 4.31M | -24.2% |
| FY2021 | 2021-12-31 | 5.69M | — |
Deferred Income Tax vs competitors
How USPH compares with its peers on the latest reported figures
- USPH's LTM Mar 2026 deferred income tax of $9.45M is the 6th largest of the 11 companies compared; the peer median is $3.86M.
- Its year-over-year change of +9.1% is the 6th highest of 9, against a peer median of +127.9%.
- Deferred income tax amounts to 1.3% of revenue for USPH, versus a peer median of 0.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $42.34M | +57.5% | +37.8% | 1.5% | |
| LTM Mar 2026 | $30.65M | +198.2% | +59.7% | 0.6% | |
| LTM Mar 2026 | $24.14M | +302.6% | — | 3.1% | |
| LTM Aug 2026 | $23.67M | -56.6% | +8.1% | 2.7% | |
| LTM Mar 2026 | $21.28M | +595.4% | +56.1% | 1.1% | |
| LTM Mar 2026 | $9.45M | +9.1% | +38.3% | 1.3% | |
| LTM Mar 2026 | $7.72M | +0.5% | — | 0.6% | |
| LTM Mar 2026 | $2.02M | -176.6% | -33.0% | 0.1% | |
| LTM Mar 2026 | $1.87M | +235.5% | — | 0.2% | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Jan 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding USPH) | $3.86M | +127.9% | +37.8% | 0.6% | |
Competitors are the stored peer set for USPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 57.92M | 43.41M | 37.22M | 45.6M | 58.01M |
| Depreciation & Amortization | 11.59M | 14.74M | 15.7M | 18.68M | 22.39M |
| Deferred Income Tax | 5.69M | 4.31M | 4.49M | 5.37M | 11.41M |
| Stock-Based Compensation | 7.87M | 7.26M | 7.24M | 7.82M | 8.27M |
| Change in Working Capital | (11.78M) | (21.43M) | (4.93M) | (12.4M) | (27.19M) |
| Accounts Receivables | (10.96M) | (10.28M) | (6M) | (11.89M) | (9.06M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | (7.76M) | 15K | 0 | (7.8M) |
| Other Working Capital | (824K) | (3.4M) | 1.06M | (510K) | (10.33M) |
| Other Non-Cash Items | 5.12M | 10.24M | 22.27M | 9.88M | 2.18M |
| Operating Cash Flow | 76.41M | 58.54M | 81.98M | 74.94M | 75.06M |
| Capital Expenditures | (8.2M) | (8.25M) | (9.29M) | (9.19M) | (14.07M) |
| Acquisitions (Net) | (116.09M) | (74.28M) | (36.87M) | (142.04M) | (24.95M) |
| Purchases of Investments | 0 | (373K) | 0 | 0 | 0 |
| Sales of Investments | 0 | 373K | 0 | 0 | 0 |
| Other Investing Activities | 152K | 1.26M | 1.15M | 1.77M | 2.31M |
| Investing Cash Flow | (124.14M) | (81.27M) | (45.02M) | (149.45M) | (36.71M) |
| Debt Repayment | 93.1M | 64.2M | (39.15M) | 4.3M | 8.06M |
| Common Stock Issued | 0 | 0 | 163.65M | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (5.57M) |
| Dividends Paid | (18.77M) | (21.32M) | (24.13M) | (26.54M) | (27.36M) |
| Other Financing Activities | (30.96M) | (17.12M) | (16.1M) | (14.71M) | (19.27M) |
| Financing Cash Flow | 43.38M | 25.76M | 84.27M | (36.95M) | (44.14M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (4.35M) | 3.03M | 121.23M | (111.46M) | (5.79M) |
| Free Cash Flow | 68.21M | 50.29M | 72.68M | 65.75M | 60.99M |
U.S. Physical Therapy, Inc.
NYSE:USPH
Intrinsic Alpha fair value
Locked
Current Price
$95.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.